Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of androgen receptor expression on clinical characterization of metastatic breast cancer.

Oncotarget - 31 Jan 2017

Kim Ji-Yeon, Park Kyunghee, Lee Eunjin, Jung Hae Hyun, Ahn Jin Seok, Im Young-Hyuck, Park Woong-Yang, Park Yeon Hee

Abstract excerpt

In breast cancer (BC), androgen receptor (AR) expression is related to estrogen receptor (ER) and/or progesterone receptor (PgR) expression. AR expression is an indicator of good prognosis in breast cancer regardless of hormone receptor (HR) status. In this study, we evaluated the effect of AR-related gene expression on clinical characterization of metastatic BC. We performed RNA-Seq to evaluate gene expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kaplan-Meier Estimate
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Predictive Value of Tests

Share to Receptor, ErbB-2

Share to Receptors, Androgen

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 28060723
DOI: 10.18632/oncotarget.14414
PMCID: PMC5352433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of androgen receptor expression on clinical characterization of metastatic breast cancer.PMID 28060723Read ↗

Prognostic value of androgen receptor expression and molecular alterations in metastatic triple-negative or low hormone receptor breast carcinomas.Semantic proximity Read ↗

AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancerSemantic proximity Read ↗

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancersSemantic proximity Read ↗

In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkersSemantic proximity Read ↗

Differentially Expressed Genes in Matched Normal, Cancer, and Lymph Node Metastases Predict Clinical Outcomes in Patients With Breast CancerSemantic proximity Read ↗

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.Semantic proximity Read ↗

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Semantic proximity Read ↗

Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and TherapySemantic proximity Read ↗

Gene expression in metastatic breast cancer – patterns with prognostic potential in primary tumors and metastatic tissueSemantic proximity Read ↗

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast CancerSemantic proximity Read ↗

Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implicationsSemantic proximity Read ↗

Hormone Receptor-status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic LandscapeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.